AI assistant
Inotiv, Inc. — Earnings Release 2007
Aug 9, 2007
34595_rns_2007-08-09_d62d360a-a4b7-4347-ad68-b1ac1c176259.zip
Earnings Release
Open in viewerOpens in your device viewer
8-K 1 v083470_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 9, 2007
| BIOANALYTICAL
SYSTEMS, INC. |
| --- |
| (Exact
name of registrant as specified in its
charter) |
| Indiana | 0-23357 | 35-1345024 |
|---|---|---|
| (State | ||
| or other jurisdiction of incorporation or organization) | (Commission | |
| File Number) | (I.R.S. | |
| Employer Identification No.) |
| 2701
KENT AVENUE WEST
LAFAYETTE, INDIANA | 47906-1382 |
| --- | --- |
| (Address
of principal executive offices) | (Zip
Code) |
Registrant's telephone number, including area code: (765) 463-4527
The information provided in Item 2.02 and Item 9.01 of this Form 8-K is being furnished and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 and Item 9.01 of this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 2.02. Results of Operations and Financial Condition.
On August 9, 2007, Bioanalytical Systems, Inc. issued a press release announcing results for the third quarter of fiscal year 2007. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(a) Not applicable.
(b) Not applicable.
(c) Not applicable.
(d) Exhibits
99.1 Bioanalytical Systems, Inc. press release, issued August 9, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| /s/ Michael
R. Cox |
| --- |
| Michael
R. Cox |
| Vice
President, Finance and Chief Financial Officer |
Exhibit Index
Exhibit No. Description
99.1 Bioanalytical Systems, Inc. press release, issued August 9, 2007.